Literature DB >> 30403164

STAT1 regulates macrophage number and phenotype and prevents renal fibrosis after ischemia-reperfusion injury.

Stephan Kemmner1, Quirin Bachmann1, Stefanie Steiger2, Georg Lorenz1, Mohsen Honarpisheh2, Orestes Foresto-Neto2, Shijun Wang3, Javier Carbajo-Lozoya1, Verena Alt1, Christian Schulte1, Stefan Chmielewski1,4, Hans A R Bluyssen4, Uwe Heemann1, Marcus Baumann1, Maciej Lech2, Christoph Schmaderer1.   

Abstract

Renal ischemia-reperfusion injury (IRI) leads to acute kidney injury or delayed allograft function, which predisposes to fibrosis in the native kidney or kidney transplant. Here we investigated the role of the signal transducer and activator of transcription 1 (STAT1) in inflammatory responses following renal IRI. Our study showed that a subsequent stimulation of Janus-activated kinase 2/STAT1 and Toll-like receptor 4 pathways led to greater STAT1 activation followed by increased cytokine transcription compared with single-pathway stimulation in murine renal tubular cells. Moreover, we observed increased activation of STAT1 under hypoxic conditions. In vivo, STAT1-/- mice displayed less acute tubular necrosis and decreased macrophage infiltration 24 h after renal ischemia. However, investigation of the healing phase (30 days after IRI) revealed significantly more fibrosis in STAT1-/- than in wild-type kidneys. In addition, we demonstrated increased macrophage infiltration in STAT1-/- kidneys. Flow cytometry analysis revealed that STAT1 deficiency drives an alternatively activated macrophage phenotype, which is associated with downregulated cluster of differentiation 80 expression, decreased intracellular reactive oxygen species production, and enhanced ability for phagocytosis. Furthermore, we detected immunohistochemically enhanced STAT1 expression in human renal allograft biopsies with no interstitial fibrosis/tubular atrophy (IF/TA) compared with specimens with severe IF/TA without specific etiology. Thus, STAT1 activation drives macrophages toward an alternatively activated phenotype and enhances fibrogenesis indicating a potential STAT1-driven protective mechanism in tissue repair after ischemic injury.

Entities:  

Keywords:  STAT1; acute kidney injury; interstitial fibrosis and tubular atrophy; renal fibrosis; renal ischemia-reperfusion injury

Mesh:

Substances:

Year:  2018        PMID: 30403164     DOI: 10.1152/ajprenal.00004.2018

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  10 in total

Review 1.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

2.  Regulator of Cell Cycle Protein (RGCC/RGC-32) Protects against Pulmonary Fibrosis.

Authors:  Irina G Luzina; Violeta Rus; Virginia Lockatell; Jean-Paul Courneya; Brian S Hampton; Rita Fishelevich; Alexander V Misharin; Nevins W Todd; Tudor C Badea; Horea Rus; Sergei P Atamas
Journal:  Am J Respir Cell Mol Biol       Date:  2022-02       Impact factor: 7.748

3.  Renoprotective effect of Stat1 deletion in murine aristolochic acid nephropathy.

Authors:  Wenguang Feng; Wei-Zhong Ying; Xingsheng Li; Lisa M Curtis; Paul W Sanders
Journal:  Am J Physiol Renal Physiol       Date:  2020-12-07

Review 4.  The Roles of Immune Cells in the Pathogenesis of Fibrosis.

Authors:  Enyu Huang; Na Peng; Fan Xiao; Dajun Hu; Xiaohui Wang; Liwei Lu
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

5.  Exosomal MicroRNA-374b-5p From Tubular Epithelial Cells Promoted M1 Macrophages Activation and Worsened Renal Ischemia/Reperfusion Injury.

Authors:  Chenguang Ding; Jin Zheng; Bo Wang; Yang Li; Heli Xiang; Meng Dou; Yuxi Qiao; Puxun Tian; Xiaoming Ding; Wujun Xue
Journal:  Front Cell Dev Biol       Date:  2020-11-26

6.  SS-31 Protects Liver from Ischemia-Reperfusion Injury via Modulating Macrophage Polarization.

Authors:  Longcheng Shang; Haozhen Ren; Shuai Wang; Hanyi Liu; Anyin Hu; Peng Gou; Yunzhen Lin; Jingchao Zhou; Wei Zhu; Xiaolei Shi
Journal:  Oxid Med Cell Longev       Date:  2021-04-13       Impact factor: 6.543

7.  Macrophage-Specific MCPIP1/Regnase-1 Attenuates Kidney Ischemia-Reperfusion Injury by Shaping the Local Inflammatory Response and Tissue Regeneration.

Authors:  Andrea Ribeiro; Ewelina Dobosz; Moritz Krill; Paulina Köhler; Marta Wadowska; Stefanie Steiger; Christoph Schmaderer; Joanna Koziel; Maciej Lech
Journal:  Cells       Date:  2022-01-24       Impact factor: 6.600

8.  Computational Prediction of Biomarkers, Pathways, and New Target Drugs in the Pathogenesis of Immune-Based Diseases Regarding Kidney Transplantation Rejection.

Authors:  Rafael Alfaro; Helios Martínez-Banaclocha; Santiago Llorente; Victor Jimenez-Coll; José Antonio Galián; Carmen Botella; María Rosa Moya-Quiles; Antonio Parrado; Manuel Muro-Perez; Alfredo Minguela; Isabel Legaz; Manuel Muro
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

9.  STAT1 is regulated by TRIM24 and promotes immunosuppression in head and neck squamous carcinoma cells, but enhances T cell antitumour immunity in the tumour microenvironment.

Authors:  Kelvin Anderson; Nathan Ryan; Divya Nedungadi; Felipe Lamenza; Michael Swingler; Arham Siddiqui; Abhay Satoskar; Puja Upadhaya; Maciej Pietrzak; Steve Oghumu
Journal:  Br J Cancer       Date:  2022-05-20       Impact factor: 9.075

10.  Effects of contralateral nephrectomy timing and ischemic conditions on kidney fibrosis after unilateral kidney ischemia-reperfusion injury.

Authors:  Junhua Zhang; Ruihua Shen; Hui Lin; Juan Pan; Xinyuan Feng; Ling Lin; Dan Niu; Yanjuan Hou; Xiaole Su; Chen Wang; Lihua Wang; Xi Qiao
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.